Clinical Trial Update: Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]

View source ↗

Summary

Phase 2 study update for Memgen's Ad-ISF35 cancer vaccine in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma; the trial was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ad-ISF35

Snippet

Sponsor: Januario Castro, M.D. | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-20